(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page

Left Out in the Cold: CBD as a Drug alongside Recreational Cannabis Legalization

by Jennifer P | Nov 28, 2018 | Canadian Regulatory, Natural Health Products

The cousin of the cannabinoid family that sits alone in the corner, cannabidiol (CBD) is a relatively silent member in the recreational cannabis legalization family. The non-psychoactive counterpart to THC, this compound had a much lower profile until recently. Before...

FDA proposes 40-year-old allergen survey to Gather Consumer Information

by Jennifer P | Nov 21, 2018 | Cosmetics, U.S. Regulatory

Anywhere you go its hard to not come across some form of cosmetic product. Imagine yourself as a consumer looking to purchase a tube of red lipstick.  There are more than a dozen brands capable of providing you with a vast selection for such a simple request.  With a...

Innovation meets Beauty Savvy: 5 Cosmetic Trends to Watch

by Jennifer P | Nov 7, 2018 | Cosmetics, Research/Science/Technology

1. Cannabis Usage Trends With growing global leniency on this once highly regulated and stigmatized substance, a change in perspective is having a profound effect on its use in cosmetics and other forms of personal care. Big companies like Estee Lauder are starting to...

The Green Dawn: Canadian Federal Government Legalizes Recreational Cannabis

by Rob | Oct 30, 2018 | Canadian Regulatory, Our View

The beginning of a new era, as of Wednesday October 17th, recreational cannabis has become legal across Canada. The Cannabis Act can be found on the Government of Canada website and provides a full account of this new legislation including various attributes of this...

‘Do you have the Blues?’: Blue Light Filtering Cosmetics, the Next Big Thing?

by Jennifer P | Oct 24, 2018 | Cosmetics, Research/Science/Technology

Akin to sunscreens, these new and innovative family of topical products aim to protect us from a growing problem associated with the technological world; blue light emitted from smartphones and computers.  Sunscreens with a twist of technology, blue-light filtering...
« Older Entries
Next Entries »

Recent Posts

  • Face Masks – Innovation and Opportunity
  • Interferon Beta 1a: Potentially Promising Treatment for Covid-19
  • The Sunshine Vitamin: What, Where, and How Much?
  • A Risk-Based Approach to Site License Applications
  • COVID-19 and Vitamin D: Correlation or Coincidence?

Recent Comments

    Archives

    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2020 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     


    Jennifer Porter

    Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

    Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.